Want to see FR:ICAD full AI Analyst Report?
ICAD Stock Chart & Stats
€18.96
€0.07(0.36%)
At close: 4:00 PM EDT
€18.96
€0.07(0.36%)
Day’s Range― - ―
52-Week Range€16.72 - €22.76
Previous CloseN/A
Volume76.89K
Average Volume (3M)102.66K
Market Cap
€1.28B
Enterprise Value€4.68K
Total Cash (Recent Filing)€780.90M
Total Debt (Recent Filing)€4.00B
Price to Earnings (P/E)―
Beta0.88
Next Earnings
Feb 22, 2027EPS Estimate
1.2Next Dividend Ex-DateN/A
Dividend Yield11.41%
Share Statistics
EPS (TTM)-2.47
Shares Outstanding76,234,540
10 Day Avg. Volume120,914
30 Day Avg. Volume102,657
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)0.43
Price to Sales (P/S)1.15
P/FCF Ratio-327.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€21.88Price Target Upside15.37% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)2.91
Revenue Forecast (FY)€300.37M
Bulls Say, Bears Say
Bulls Say
Recurring Healthcare Rental IncomeA portfolio of healthcare properties leased under multi-year agreements can provide recurring rental receipts and greater income visibility than transaction-only activity. This supports operational resilience and gives Icade a durable base from which to manage development and portfolio decisions over the coming quarters.
Integrated Investment And Development ModelCombining property ownership, leasing, development, and management gives Icade multiple ways to generate earnings across the real estate cycle. The healthcare emphasis also provides a defined operating focus, while the diversified model can support capital recycling and portfolio renewal over time.
Improved Leverage ProfileLeverage has improved from the 2022 peak and remains described as meaningful but not extreme for a diversified REIT. That provides a comparatively serviceable balance-sheet foundation, preserving some financial flexibility even though profitability and capital strength remain challenged.
Bears Say
Persistent Net LossesThree consecutive years of net losses and continuing negative margins show that the business is not currently converting its revenue base into dependable bottom-line earnings. Persistent losses can constrain reinvestment, weaken returns on capital, and make financial performance less predictable over the next several quarters.
Inconsistent Free Cash FlowAlthough operating cash flow has remained positive, free cash flow has repeatedly turned negative and recently weakened again in 2025. This stop-start cash generation reduces internally funded capacity for investment, debt reduction, and distributions, making future capital allocation more dependent on operating improvement.
Declining Assets And EquityThe decline in assets and equity, combined with negative returns on equity through 2025, indicates that the existing capital base has not produced attractive earnings outcomes. If this pattern persists, it may limit balance-sheet growth and reduce the company’s ability to compound value through its property portfolio.
Icade SA News
ICAD FAQ
What was Icade SA’s price range in the past 12 months?
Icade SA lowest stock price was €16.72 and its highest was €22.76 in the past 12 months.
What is Icade SA’s market cap?
Icade SA’s market cap is €1.28B.
When is Icade SA’s upcoming earnings report date?
Icade SA’s upcoming earnings report date is Feb 22, 2027 which is in 158 days.
How were Icade SA’s earnings last quarter?
Icade SA released its earnings results on Jul 21, 2026. The company reported €1.17 earnings per share for the quarter, missing the consensus estimate of €1.24 by -€0.07.
Is Icade SA overvalued?
According to Wall Street analysts Icade SA’s price is currently Undervalued.
Does Icade SA pay dividends?
Icade SA pays a Annually dividend of €1.92 which represents an annual dividend yield of 11.41%. See more information on Icade SA dividends here
What is Icade SA’s EPS estimate?
Icade SA’s EPS estimate is 1.2.
How many shares outstanding does Icade SA have?
Icade SA has 76,234,540 shares outstanding.
What happened to Icade SA’s price movement after its last earnings report?
Icade SA reported an EPS of €1.17 in its last earnings report, missing expectations of €1.24. Following the earnings report the stock price went down -0.157%.
Which hedge fund is a major shareholder of Icade SA?
Currently, no hedge funds are holding shares in FR:ICAD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Icade SA
Icade functions as a comprehensive real estate entity, actively investing in and developing properties. It specializes in crafting innovative real estate solutions and offerings tailored to evolving urban lifestyles and demands. With corporate social responsibility and innovation central to its strategic approach, Icade cultivates close relationships with a broad spectrum of urban stakeholders, including local governments, communities, businesses, their employees, and various institutions and associations. The company is a significant investor in office and healthcare properties, possessing a portfolio valued at €11.6 billion (as of June 30, 2020, on a proportionate consolidation basis), and also operates as a robust property developer, generating nearly €1 billion in economic revenues in 2019. Through these endeavors, Icade has redefined the real estate sector, championing the emergence of tomorrow's greener, smarter, and more responsible urban environments. Its operations are particularly prominent across the Greater Paris region and other major French cities. Icade is publicly traded on Euronext Paris as a French Listed Real Estate Investment Company (société d'investissement immobilier cotée, SIIC), and its primary shareholder is the Caisse des dépôts Group.
ICAD Stock 12 Month Forecast
Average Price Target
€21.88
▲(15.37% Upside)